Broussard to serve as a Director on Marsh McLennan’s Board

The Board of Directors of Marsh McLennan, a global insurance and reinsurance brokerage firm, has appointed Bruce Broussard as a Director, effective immediately. His appointment brings the total number of directors on the Board to 12.

Broussard has over 30 years of experience leading public and private healthcare organisations. He was the President of Humana in 2011 and served as Chief Executive Officer (CEO) from 2013 to 2024.

Before this, he was the CEO of McKesson Specialty/US Oncology. He joined US Oncology, which was acquired by McKesson Specialty, in 2000, and held various leadership roles, including Chief Financial Officer, President, CEO and Chairman of the Board.

Broussard also serves on the Boards of HP Inc., Cleveland Clinic and One Call. Additionally, he holds leadership positions in advocacy organisations, including The Business Council and the American Heart Association’s CEO Roundtable.

He is also the Chair of the Board of Directors of the Trust for the National Mall, a nonprofit philanthropic partner of the National Park Service dedicated to restoring and preserving the National Mall.

H. Edward Hanway, Chair of the Board of Directors, Marsh McLennan, commented on the appointment, “We are delighted to welcome Bruce to the Board. His appointment underscores our commitment to enriching our Board with broad industry expertise.”

John Doyle, President and CEO of Marsh McLennan, added, “Bruce is a terrific addition to Marsh McLennan’s Board. He brings a wealth of knowledge in the insurance and healthcare sectors, along with valuable leadership experience as a Chief Executive and Financial Officer, which will enhance our Board’s perspective on an array of important issues.”

This website states: The content on this site is sourced from the internet. If there is any infringement, please contact us and we will handle it promptly.